M
Marsden Eye Specialists | Parramatta, Australia
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
KHK4951
Irinotecan
5-Fluorouracil
Binimetinib
Faricimab
Encorafenib
IONIS-FB-LRx
EXN407
Cetuximab
Bimatoprost
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
4 of 9 total trials
THN391-OPT-101 is a study assessing safety and preliminary efficacy of THN391 in patients with diabetic macular edema (DME) given as monotherapy.
Enrolling
Diabetic Macular Edema
Diabetic Retinopathy
Drug: THN391 MAD
The purpose of this study is to evaluate efficacy and safety of KHK4951 eye drops in patients with DME.
Enrolling
Diabetic Macular Edema (DME)
Drug: KHK4951
Drug: Aflibercept Injection
The purpose of this study is to evaluate efficacy and safety of KHK4951 eye drops in patients with nAMD.
Enrolling
Neovascular Age-Related Macular Degeneration (nAMD)
Drug: Aflibercept Injection
Drug: KHK4951
This study will assess a pragmatic, treat and extend regimen of faricimab against the standard of a fixed dosing regimen.
Enrolling
Diabetic Macular Edema
Drug: Faricimab
Trial sponsors
E
T
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems